245 related articles for article (PubMed ID: 8777177)
1. On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993.
Griffin AM; Butow PN; Coates AS; Childs AM; Ellis PM; Dunn SM; Tattersall MH
Ann Oncol; 1996 Feb; 7(2):189-95. PubMed ID: 8777177
[TBL] [Abstract][Full Text] [Related]
2. Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster.
Pirri C; Bayliss E; Trotter J; Olver IN; Katris P; Drummond P; Bennett R
Support Care Cancer; 2013 Mar; 21(3):735-48. PubMed ID: 22976921
[TBL] [Abstract][Full Text] [Related]
3. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
[TBL] [Abstract][Full Text] [Related]
4. Antiemetic effectiveness and nausea and vomiting incidence during capecitabine and oxaliplatin chemotherapy.
Chan A; Tan SH; Low XH; Yap KY
Nurs Res; 2012; 61(6):405-12. PubMed ID: 22960588
[TBL] [Abstract][Full Text] [Related]
5. On the receiving end: have patient perceptions of the side-effects of cancer chemotherapy changed since the twentieth century?
Vardy JL; Liew A; Warby A; Elder A; Keshet I; Devine R; Ouliaris C; Renton C; Tattersall MHN; Dhillon HM
Support Care Cancer; 2022 Apr; 30(4):3503-3512. PubMed ID: 35015133
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced nausea and vomiting (CINV) in 190 colorectal cancer patients: a prospective registration study by the CINV study group of Japan.
Tsuji Y; Baba H; Takeda K; Kobayashi M; Oki E; Gotoh M; Yoshida K; Shimokawa M; Kakeji Y; Aiba K
Expert Opin Pharmacother; 2017 Jun; 18(8):753-758. PubMed ID: 28395603
[TBL] [Abstract][Full Text] [Related]
7. Results of a compassionate-use program using intravenous ondansetron to prevent nausea and vomiting in patients receiving emetogenic cancer chemotherapy.
Berry WR; House KW; Lee JT; Plagge PB; Meshad MW; Grapski R
Semin Oncol; 1992 Dec; 19(6 Suppl 15):33-7. PubMed ID: 1485180
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan.
Baba Y; Baba H; Yamamoto S; Shimada H; Shibata T; Miyazaki T; Yoshikawa T; Nakajima Y; Tsuji Y; Shimokawa M; Kitagawa Y; Aiba K
Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 27001532
[TBL] [Abstract][Full Text] [Related]
9. Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy.
Treish I; Shord S; Valgus J; Harvey D; Nagy J; Stegal J; Lindley C
Support Care Cancer; 2003 Aug; 11(8):516-21. PubMed ID: 12836088
[TBL] [Abstract][Full Text] [Related]
10. Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists.
de Boer-Dennert M; de Wit R; Schmitz PI; Djontono J; v Beurden V; Stoter G; Verweij J
Br J Cancer; 1997; 76(8):1055-61. PubMed ID: 9376266
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of using the Multinational Association of Supportive Care in Cancer Antiemesis Tool for assessment of chemotherapy-induced nausea and vomiting at the Tom Baker Cancer Centre.
Warr JK; Chambers CR; Cusano FL; Cuthbert CA; Mah MS
J Oncol Pharm Pract; 2015 Oct; 21(5):348-57. PubMed ID: 24938292
[TBL] [Abstract][Full Text] [Related]
12. Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology population.
Lindley CM; Bernard S; Fields SM
J Clin Oncol; 1989 Aug; 7(8):1142-9. PubMed ID: 2787840
[TBL] [Abstract][Full Text] [Related]
13. Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres.
O'Brien BJ; Rusthoven J; Rocchi A; Latreille J; Fine S; Vandenberg T; Laberge F
CMAJ; 1993 Aug; 149(3):296-302. PubMed ID: 8339175
[TBL] [Abstract][Full Text] [Related]
14. Patient-practitioner perception gap in treatment-induced nausea and vomiting.
Vidall C; Sharma S; Amlani B
Br J Nurs; 2016 Sep; 25(16):S4-S11. PubMed ID: 27615540
[TBL] [Abstract][Full Text] [Related]
15. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
Bloechl-Daum B; Deuson RR; Mavros P; Hansen M; Herrstedt J
J Clin Oncol; 2006 Sep; 24(27):4472-8. PubMed ID: 16983116
[TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial.
Tsuji D; Suzuki K; Kawasaki Y; Goto K; Matsui R; Seki N; Hashimoto H; Hama T; Yamanaka T; Yamamoto N; Itoh K
Support Care Cancer; 2019 Mar; 27(3):1139-1147. PubMed ID: 30094732
[TBL] [Abstract][Full Text] [Related]
17. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.
Phillips RS; Gopaul S; Gibson F; Houghton E; Craig JV; Light K; Pizer B
Cochrane Database Syst Rev; 2010 Sep; (9):CD007786. PubMed ID: 20824866
[TBL] [Abstract][Full Text] [Related]
18. What occurs in the other 20% of cancer patients with chemotherapy-induced nausea and vomiting (CINV)? A single-institution qualitative study.
Childs DS; Looker S; Le-Rademacher J; Ridgeway JL; Breitkopf CR; Jatoi A
Support Care Cancer; 2019 Jan; 27(1):249-255. PubMed ID: 29938306
[TBL] [Abstract][Full Text] [Related]
19. Management of chemotherapy-induced nausea and vomiting.
Zubairi IH
Br J Hosp Med (Lond); 2006 Aug; 67(8):410-3. PubMed ID: 16918094
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance).
Kottschade L; Novotny P; Lyss A; Mazurczak M; Loprinzi C; Barton D
Support Care Cancer; 2016 Jun; 24(6):2661-7. PubMed ID: 26768436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
